+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Injectable Drug Delivery Market by Device Type (Conventional Injection Devices, Self-injection Devices), Usability (Disposable, Reusable), Therapeutic Application, End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977713
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Injectable Drug Delivery Market size was estimated at USD 972.25 billion in 2023 and expected to reachUSD 1.04 trillion in 2024, and is expected to grow at a CAGR of 7.58% to reachUSD 1.62 trillion by 2030.

Technological innovations in needle technology, such as the development of needle-free injection systems, contribute to market growth. The rise in conditions such as diabetes and cancer necessitates robust drug delivery systems, including injectables. Faster approval processes for new drugs and devices help drive the adoption of advanced injectable technologies. However, maintaining the integrity of drugs through specialized storage and handling needs adds complexity, limiting the market scope. Stringent global regulations may delay product launches, challenging market growth. Moreover, the development of smart injection devices that adjust doses based on real-time patient data can generate the potential for personalized treatment. Ongoing research into biodegradable implants reduces the need for frequent injections, creating significant potential for market expansion.

Regional Insights

The Americas region has significance in the global injectable drug delivery market due to its advanced healthcare infrastructure, strong emphasis on research and development, and significant healthcare spending. The focus in the United States and Canada is increasingly on biologics and biosimilars owing to their efficacy in treating chronic diseases such as diabetes and cancer. Recent patents in the region have highlighted innovations in needle-free injections and sustained-release formulations, enhancing patient compliance. Countries within the EU exhibit a strong pipeline for biologics and advanced drug delivery devices backed by rigorous regulatory standards. Recent EU investments focus on improving drug formulations and reducing the discomfort associated with injections. The Middle East and Africa region experiences varying growth levels driven by disparities in healthcare infrastructure. The Middle East region benefits from the luxury healthcare facilities in countries such as the UAE and Saudi Arabia that focus on adopting advanced drug delivery systems, including smart injectables. Africa is a developing region in this sector, showing potential due to increasing healthcare investments and rising awareness about advanced therapeutic measures. In the Asia-Pacific region, China is rapidly advancing in the injectable drug delivery field, buoyed by large-scale investments in healthcare and pharmaceutical R&D. Japan has introduced several reforms to expedite the approval process for new drugs, including injectables. India's injectable drug delivery market is burgeoning, facilitated by the large generic drugs industry and a growing focus on chronic disease management.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Injectable Drug Delivery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Technological advancements in needle technology
  • Increasing prevalence of chronic diseases
  • Significant rise in elderly population worldwide

Market Restraints

  • High development costs of injectable drug delivery solutions

Market Opportunities

  • Development of smart injection devices
  • Increasing demand for self-administration devices

Market Challenges

  • Low patient compliance of needles and lack of training in using injectable devices

Market Segmentation Analysis

  • Device Type: Increasing preference for self-injection devices due to ease of use
  • End-user: Exploring applications in home care settings due to safety and portability

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Injectable Drug Delivery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Injectable Drug Delivery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Stevanato Group Launches Vertiva, An Innovative On-Body Drug Delivery System for Enhanced Patient Care and Sustainability

Stevanato Group, S.p.A. has launched Vertiva, its advanced On-Body Delivery System (OBDS), designed to revolutionize patient medication administration by supporting both basal and bolus injections. Engineered to cater to a diverse array of subcutaneous therapies, Vertiva features a novel, two-part design comprising a single-use, pre-filled 3mL ISO cartridge pod and a reusable multi-use controller.

Altaviz Introduces AltaVISC, A Revolutionary Auto-injector Platform Enhancing Drug Delivery Efficiency

Altaviz, a medical device manufacturer, has launched AltaVISC, a cutting-edge auto-injector platform designed to effectively administer a diverse range of drug therapies. Developed in collaboration with affiliate company Picocy, this innovative platform incorporates Pico-Cylinder technology to manage the delivery of both high-volume and viscous medications. AltaVISC stands out with its ability to handle shear-sensitive molecules and viscous biologics, maintaining a consistent form factor while offering a wide pressure range for precise control under various environmental conditions.

Launch of UDENYCA Autoinjector Enhances Patient Accessibility and Administration Efficiency

Coherus BioSciences, Inc. has announced the commercial availability of the UDENYCA autoinjector in the United States, offering a new, user-friendly option for administering the pegfilgrastim biosimilar. Designed for use either in medical facilities or at home, the UDENYCA® autoinjector simplifies the injection process, delivering medication in under ten seconds and potentially reducing the occurrence of febrile neutropenia following chemotherapy. The introduction of this autoinjector aligns with Coherus's strategic goal to diversify their product offerings, ensuring they meet broad market needs.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Injectable Drug Delivery Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Injectable Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Antares Pharma by Halozyme Therapeutics, Becton, Dickinson and Company, Eli Lilly and Company, Emperra GmbH, Enable Injections LLC, F. Hoffman - La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PlC, Novo Nordisk A/S, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SiO2 Medical Products, Stevanato Group, Tandem Diabetes Care, West Pharmaceutical Services, Inc., and Wilhelm Haselmeier GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Injectable Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Device Type

  • Conventional Injection Devices

Self-injection Devices

  • Autoinjectors
  • Needle-free Injectors
  • Pen Injectors
  • Wearable Injectors

Usability

  • Disposable
  • Reusable

Therapeutic Application

  • Autoimmune Diseases
  • Cancer
  • Chronic Diseases
  • Hormonal Therapies
  • Infectious Diseases

End-user

  • Home Care Settings
  • Hospitals & Clinics

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Technological advancements in needle technology
5.1.1.2. Increasing prevalence of chronic diseases
5.1.1.3. Significant rise in elderly population worldwide
5.1.2. Restraints
5.1.2.1. High development costs of injectable drug delivery solutions
5.1.3. Opportunities
5.1.3.1. Development of smart injection devices
5.1.3.2. Increasing demand for self-administration devices
5.1.4. Challenges
5.1.4.1. Low patient compliance of needles and lack of training in using injectable devices
5.2. Market Segmentation Analysis
5.2.1. Device Type: Increasing preference for self-injection devices due to ease of use
5.2.2. End-user: Exploring applications in home care settings due to safety and portability
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Injectable Drug Delivery Market, by Device Type
6.1. Introduction
6.2. Conventional Injection Devices
6.3. Self-injection Devices
7. Injectable Drug Delivery Market, by Usability
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Injectable Drug Delivery Market, by Therapeutic Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cancer
8.4. Chronic Diseases
8.5. Hormonal Therapies
8.6. Infectious Diseases
9. Injectable Drug Delivery Market, by End-user
9.1. Introduction
9.2. Home Care Settings
9.3. Hospitals & Clinics
10. Americas Injectable Drug Delivery Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Injectable Drug Delivery Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Injectable Drug Delivery Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Stevanato Group Launches Vertiva, An Innovative On-Body Drug Delivery System for Enhanced Patient Care and Sustainability
13.3.2. Altaviz Introduces AltaVISC, A Revolutionary Auto-injector Platform Enhancing Drug Delivery Efficiency
13.3.3. Launch of UDENYCA Autoinjector Enhances Patient Accessibility and Administration Efficiency
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. INJECTABLE DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. INJECTABLE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INJECTABLE DRUG DELIVERY MARKET DYNAMICS
FIGURE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. INJECTABLE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. INJECTABLE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. INJECTABLE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL INJECTION DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL INJECTION DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY PEN INJECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISPOSABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REUSABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 80. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 81. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 82. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 83. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 84. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 85. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 90. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 91. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 92. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 93. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 94. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 95. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 133. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 134. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 135. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 136. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 137. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 138. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 139. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 144. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 145. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 146. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 147. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 148. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 149. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 154. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 164. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 165. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 166. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 167. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 168. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 169. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 174. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 184. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 194. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 204. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 213. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 214. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 224. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 225. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 226. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 227. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 228. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 229. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 234. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 255. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 256. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 257. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 258. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 259. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 260. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 261. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 266. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 267. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 268. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 269. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 270. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 271. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 276. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 277. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 278. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 279. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 280. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 281. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 286. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 287. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 288. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 289. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 290. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 291. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 294. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 295. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 296. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 297. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 298. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 299. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 300. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 301. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 302. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 303. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 304. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 305. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 306. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 307. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 308. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 315. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
TABLE 316. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
TABLE 317. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2023 (USD MILLION)
TABLE 318. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2024-2030 (USD MILLION)
TABLE 319. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2023 (USD MILLION)
TABLE 320. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2024-2030 (USD MILLION)
TABLE 321. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2023 (USD MILLION)
TABL

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Antares Pharma by Halozyme Therapeutics
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Emperra GmbH
  • Enable Injections LLC
  • F. Hoffman - La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PlC
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Ravimed Sp. z o.o.
  • Recipharm AB
  • Sanofi S.A.
  • SiO2 Medical Products
  • Stevanato Group
  • Tandem Diabetes Care
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.04 Trillion
Forecasted Market Value ( USD ) by 2030 $ 1.62 Trillion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal

Related Topics

Related Reports

Global Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel, Patient Care Setting, & Region - Forecast to 2029 - Product Image

Global Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel, Patient Care Setting, & Region - Forecast to 2029

  • Report
  • 387 Pages
  • Global
From
Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Global Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Blood Factors, Cytokines, Immunoglobulin), Injection Routes, Application - Forecast 2024-2030 - Product Image

Global Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Blood Factors, Cytokines, Immunoglobulin), Injection Routes, Application - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Injectable Drug Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Injectable Drug Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 114 Pages
  • Global
From
Global Injectable Drug Delivery Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Global Injectable Drug Delivery Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 158 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.